KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Income from Continuing Operations (2017 - 2025)

Historic Income from Continuing Operations for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to -$200.0 million.

  • Moderna's Income from Continuing Operations fell 163846.15% to -$200.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 billion, marking a year-over-year decrease of 4010.79%. This contributed to the annual value of -$3.6 billion for FY2024, which is 2445.91% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Income from Continuing Operations is -$200.0 million, which was down 163846.15% from -$825.0 million recorded in Q2 2025.
  • Moderna's 5-year Income from Continuing Operations high stood at $4.9 billion for Q4 2021, and its period low was -$3.6 billion during Q3 2023.
  • Moreover, its 5-year median value for Income from Continuing Operations was $79.0 million (2023), whereas its average is $541.7 million.
  • As far as peak fluctuations go, Moderna's Income from Continuing Operations skyrocketed by 247606.84% in 2021, and later plummeted by 163846.15% in 2025.
  • Over the past 5 years, Moderna's Income from Continuing Operations (Quarter) stood at $4.9 billion in 2021, then tumbled by 69.91% to $1.5 billion in 2022, then plummeted by 85.19% to $217.0 million in 2023, then plummeted by 616.13% to -$1.1 billion in 2024, then soared by 82.14% to -$200.0 million in 2025.
  • Its last three reported values are -$200.0 million in Q3 2025, -$825.0 million for Q2 2025, and -$971.0 million during Q1 2025.